Advertisements
Advertisements
प्रश्न
In humans, somatic gene therapy was carried out to correct an immunodeficiency disease. Name this disease.
Advertisements
उत्तर
SCIO (Severe Combined Immunodeficiency)
Explanation:
Somatic gene therapy typically involves either replacing a dysfunctional gene with a functional or therapeutic gene or reducing the negative effects that the defective gene causes, depending on the type of illness.
APPEARS IN
संबंधित प्रश्न
State the role of C-peptide in human insulin.
Vaccines that use components of a pathogenic organism rather than the whole organism are called ____________.
Mention the number of primers required in each cycle of PCR. Write the role of primers and DNA polymerase in PCR. Name the source organism of the DNA polymerase used in PCR.
What is genetically engineered Insulin?
If a person thinks he is infected with HIV, due to unprotected sex, and goes for a blood test. Do you think a test such as ELISA will help? If so why? If not, why?
Due to which of the following reasons insulin extracted from pancreas of slaughtered animals cannot be used in humans to treat diabetes?
With regard to insulin choose the correct options.
- C-peptide is not present in mature insulin.
- The insulin produced by rDNA technology has C-peptide.
- The pro-insulin has C-peptide.
- A-peptide and B-peptide of insulin are interconnected by disulphide bridges.
Choose the correct answer from the options given below.
Who was the first patient who was given gene therapy? Why was the given treatment recurrent in nature?
The diagram given below represents the schematic structure of proinsulin, which undergoes certain modifications before it becomes a fully functional insulin.
Study the diagram carefully and answer the questions that follow:

- State the change the proinsulin undergoes to become fully functional.
- Name the modern scientific technique used for the production of human insulin.
- How are the two polypeptide chains of the fully functional insulin held together?
Illustrate using any one example of transgenic bacteria.
